<- Go Home
Kenvue Inc.
Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee’s, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. Its Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women’s health, wound, and other care products under the Listerine, Johnson’s, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
Market Cap
$44.9B
Volume
17.4M
Cash and Equivalents
$1.1B
EBITDA
$3.6B
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$9.0B
Profit Margin
58.14%
52 Week High
$24.46
52 Week Low
$17.67
Dividend
3.51%
Price / Book Value
4.63
Price / Earnings
43.47
Price / Tangible Book Value
-5.85
Enterprise Value
$52.5B
Enterprise Value / EBITDA
14.53
Operating Income
$2.9B
Return on Equity
9.87%
Return on Assets
6.88
Cash and Short Term Investments
$1.1B
Debt
$8.7B
Equity
$9.7B
Revenue
$15.5B
Unlevered FCF
$1.9B
Sector
Personal Care Products
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium